Drugs / Lopinavir / ritonavir
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07601074 Comparator | Jun 2026 → Oct 2027 expected | human papilloma virus infection | Daré Bioscience, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lopinavir / ritonavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07601074 ↗ |